Wheatland Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-5,818
| Closed | -$342K | – | 59 |
|
|
2019
Q4 | $342K | Sell |
5,818
-319
| -5% | -$18.8K | 0.44% | 70 |
|
|
2019
Q3 | $327K | Sell |
6,137
-8,018
| -57% | -$427K | 0.3% | 76 |
|
|
2019
Q2 | $708K | Buy |
14,155
+1
| +0% | +$50 | 0.53% | 58 |
|
|
2019
Q1 | $739K | Sell |
14,154
-662
| -4% | -$34.6K | 0.56% | 58 |
|
|
2018
Q4 | $708K | Buy |
14,816
+2
| +0% | +$96 | 0.62% | 54 |
|
|
2018
Q3 | $744K | Buy |
14,814
+1
| +0% | +$50 | 0.56% | 56 |
|
|
2018
Q2 | $746K | Buy |
14,813
+209
| +1% | +$10.5K | 0.6% | 56 |
|
|
2018
Q1 | $713K | Buy |
14,604
+2
| +0% | +$98 | 0.59% | 57 |
|
|
2017
Q4 | $647K | Buy |
14,602
+1
| +0% | +$44 | 0.52% | 59 |
|
|
2017
Q3 | $741K | Buy |
14,601
+1
| +0% | +$51 | 0.63% | 51 |
|
|
2017
Q2 | $787K | Buy |
14,600
+2
| +0% | +$108 | 0.71% | 52 |
|
|
2017
Q1 | $769K | Hold |
14,598
| – | – | 0.69% | 52 |
|
|
2016
Q4 | $703K | Buy |
14,598
+1
| +0% | +$48 | 0.62% | 55 |
|
|
2016
Q3 | $787K | Sell |
14,597
-42
| -0.3% | -$2.26K | 0.74% | 50 |
|
|
2016
Q2 | $793K | Buy |
14,639
+1
| +0% | +$54 | 0.76% | 47 |
|
|
2016
Q1 | $742K | Buy |
14,638
+2
| +0% | +$101 | 0.76% | 48 |
|
|
2015
Q4 | $738K | Buy |
14,636
+1
| +0% | +$50 | 0.75% | 46 |
|
|
2015
Q3 | $703K | Buy |
14,635
+1
| +0% | +$48 | 0.76% | 46 |
|
|
2015
Q2 | $762K | Sell |
14,634
-159
| -1% | -$8.28K | 0.73% | 50 |
|
|
2015
Q1 | $853K | Buy |
14,793
+2
| +0% | +$115 | 0.85% | 46 |
|
|
2014
Q4 | $790K | Buy |
14,791
+1
| +0% | +$53 | 0.77% | 51 |
|
|
2014
Q3 | $850K | Buy |
14,790
+1
| +0% | +$57 | 0.85% | 45 |
|
|
2014
Q2 | $1.66M | Buy |
14,789
+1
| +0% | +$112 | 1.51% | 27 |
|
|
2014
Q1 | $988K | Hold |
14,788
| – | – | 1.01% | 41 |
|
|
2013
Q4 | $987K | Buy |
+14,788
| New | +$987K | 1.03% | 42 |
|